EMPLOYMENT AGREEMENTEmployment Agreement • April 6th, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 6th, 2015 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made by and between aTyr Pharma, Inc., a Delaware corporation (the “Company”), and John D. Mendlein (“Employee”).
December 20, 2013 Mr. Frederic Chereau Dear Fred,Employment Agreement • April 6th, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances)
Contract Type FiledApril 6th, 2015 Company IndustryThis letter is a formal offer setting forth the principal terms for you to join aTyr Pharma, Inc. (the “Company”), a Delaware corporation, which is located in San Diego, California. This offer is contingent upon satisfactory completion of a background check.
AMENDED AND RESTATED RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and aTYR PHARMA, INC. a Delaware corporationResearch Funding and Option Agreement • April 6th, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 6th, 2015 Company Industry JurisdictionThis Agreement is entered into this 19th day of January 2015 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 (“TSRI”), and aTyr Pharma, Inc., a Delaware corporation located at 3545 John Hopkins Court, Suite #250, San Diego, CA 92121 (“Sponsor”), with respect to the facts set forth below.
ContractWarrant Agreement • April 6th, 2015 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 6th, 2015 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE SOLD, OFFERED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.